TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 22488751

Group type: EXPERIMENTAL
Intervention: Physiotherapy treatment with rectal balloon training and pelvic floor muscle training
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Longer time since FI onset
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Use of constipating medication
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Any obstetric factor
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Experiencing minor embarrassment
Number of subjects: 80
Study: 20048226

Group type: EXPERIMENTAL
Intervention: 2-session group coping skills intervention targeting personality profiles
Number of subjects: 732

Group type: COMPARATOR
Intervention: Control no-intervention condition
Number of subjects: 732
Study: 18633251

Group type: EXPERIMENTAL
Intervention: Carboplatin AUC 6.0 day 1 and paclitaxel 70 mg/m2 day 1, 8, 15 every 4 weeks followed by gemcitabine 1.0 g/m2 day 1, 8, 15 every 4 weeks (Group CP)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Carboplatin AUC 2.0 and gemcitabine 0.8 g/m2 day 1, 8 every 3 weeks followed by docetaxel 60 mg/m2 day 1, 8 every 3 weeks (Group CG)
Number of subjects: 51
Study: 16224532

Group type: EXPERIMENTAL
Intervention: Modified Bass method
Number of subjects: 40

Group type: COMPARATOR
Intervention: Vertical method
Number of subjects: 40
Study: 12898873

Group type: EXPERIMENTAL
Intervention: Children with vitiligo
Number of subjects: 38

Group type: COMPARATOR
Intervention: Control group (healthy children with mild pityriasis capitis)
Number of subjects: 38
Study: 10224335

Group type: EXPERIMENTAL
Intervention: Rifametane (300 mg single oral dose)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Rifampicin (300 mg single oral dose)
Number of subjects: 8
Study: 9023072

Group type: EXPERIMENTAL
Intervention: Contingency contract condition
Number of subjects: 39

Group type: COMPARATOR
Intervention: No contingencies condition
Number of subjects: 39
Study: 1801540

Group type: EXPERIMENTAL
Intervention: Selegiline (10 mg/day)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 54
Study: 6742536

Group type: EXPERIMENTAL
Intervention: Midazolam (0.1 mg/kg for <65 years; 0.085 mg/kg for ≥65 years)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Diazepam (0.2 mg/kg for <65 years; 0.15 mg/kg for ≥65 years)
Number of subjects: 0
Study: 31812854

Group type: EXPERIMENTAL
Intervention: Child and parent satisfaction ratings (Arm 1)
Number of subjects: 600

Group type: COMPARATOR
Intervention: Parent report only (Arm 2)
Number of subjects: 600
Study: 29304140

Group type: EXPERIMENTAL
Intervention: Active Exercise (AE)
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Manual Lymphatic Drainage (MLD)
Number of subjects: 106
Study: 26083427

Group type: EXPERIMENTAL
Intervention: Lidocaine (2%) via intravenous bolus (1.5 mg/kg) followed by infusion at 2 mg/kg/h until the end of surgery
Number of subjects: 94

Group type: COMPARATOR
Intervention: Normal saline (same volume as lidocaine)
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Lidocaine (2%)
Number of subjects: 94
Study: 24291444

Group type: EXPERIMENTAL
Intervention: Singing intervention
Number of subjects: 24

Group type: COMPARATOR
Intervention: Active music therapy control
Number of subjects: 24
Study: 22552687

Group type: EXPERIMENTAL
Intervention: Diet only (DO; n = 14, ≈ 6000 kJ/day)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Diet and aerobic exercise (DA; n = 16, ≈ 6000 kJ/day and five walking sessions/week)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Diet and combined aerobic-resistance exercise (DC; n = 20, ≈ 6000 kJ/day, three walking and two strength sessions/week)
Number of subjects: 50
Study: 20196183

Group type: EXPERIMENTAL
Intervention: Aripiprazole
Number of subjects: 23

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study: 17666280

Group type: EXPERIMENTAL
Intervention: Alternative non-heparin anticoagulants (danaparoid, lepirudin, argatroban)
Number of subjects: 0
Study: 16135578

Group type: EXPERIMENTAL
Intervention: Drospirenone 3 mg and Ethinyl Estradiol 20 microg (24/4 regimen)
Number of subjects: 450

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 450
Study: 11906496

Group type: EXPERIMENTAL
Intervention: Clinafloxacin monotherapy (200 mg every 12 h)
Number of subjects: 419

Group type: COMPARATOR
Intervention: Ceftazidime (2 g every 8 h) plus Amikacin (15 mg/kg per day)
Number of subjects: 419
Study: 9949709

Group type: EXPERIMENTAL
Intervention: Mood music during word generation and recall (pleasantness dimension)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mood music during word generation and recall (arousal dimension)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Simultaneous changes in both dimensions of mood (pleasantness and arousal)
Number of subjects: 0
Study: 7751885

Group type: EXPERIMENTAL
Intervention: TURB plus BCG
Number of subjects: 86

Group type: COMPARATOR
Intervention: TURB
Number of subjects: 86
Study: 2405347

Group type: EXPERIMENTAL
Intervention: In vitro antibody production of HIV‐specific IgG
Number of subjects: 0
Study: 6449891

Group type: EXPERIMENTAL
Intervention: Synthetic regular GnRH
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Analogue (D-TRp6) GnRH
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 31379236

Group type: EXPERIMENTAL
Intervention: Perioperative amiodarone
Number of subjects: 12758
Study: 29219599

Group type: EXPERIMENTAL
Intervention: Extrapolation to the zero noise limit
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Resampling randomized circuits according to a quasiprobability distribution
Number of subjects: 0
Study: 25872505

Group type: EXPERIMENTAL
Intervention: Online self-help program (deprexis®) with 12 weekly tasks during inpatient treatment
Number of subjects: 240

Group type: COMPARATOR
Intervention: Access to an online platform with weekly updated information on depression
Number of subjects: 240
Study: 23798331

Group type: EXPERIMENTAL
Intervention: Cold knife (n = 8)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Electrocautery (n = 7)
Number of subjects: 15
Study: 21173780

Group type: COMPARATOR
Intervention: Non-invasive cardiac output measurements using Innocor at rest
Number of subjects: 9

Group type: COMPARATOR
Intervention: Non-invasive cardiac output measurements using Innocor during arm-crank exercise
Number of subjects: 9

Group type: COMPARATOR
Intervention: Non-invasive cardiac output measurements using Innocor during wheelchair exercise
Number of subjects: 9
Study: 19728564

Group type: EXPERIMENTAL
Intervention: Compounds 1-7
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Compounds 1, 3, 4, 5, 6, and 7
Number of subjects: 2

Group type: COMPARATOR
Intervention: Compound 5
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Jurkat cells
Number of subjects: 2
Study: 17761550

Group type: EXPERIMENTAL
Intervention: Natalizumab
Number of subjects: 625
Study: 15611489

Group type: EXPERIMENTAL
Intervention: Manipulation plus exercise
Number of subjects: 131

Group type: COMPARATOR
Intervention: Exercise alone
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: Manipulation
Number of subjects: 131
Study: 11763110

Group type: EXPERIMENTAL
Intervention: Losartan (50 mg)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Losartan (100 mg)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Amlodipine (10 mg)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Promethazine (10 mg)
Number of subjects: 6
Study: 9722810

Group type: EXPERIMENTAL
Intervention: Community-based outreach HIV intervention
Number of subjects: 250

Group type: COMPARATOR
Intervention: Control group (no outreach services)
Number of subjects: 250
Study: 9032106

Group type: EXPERIMENTAL
Intervention: Nisoldipine (20-40 mg once daily)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Lisinopril (10-20 mg once daily)
Number of subjects: 49
Study: 1742648

Group type: EXPERIMENTAL
Intervention: Oral sodium cromoglycate
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 7099364

Group type: EXPERIMENTAL
Intervention: Amitriptyline 50 mg
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 31852892

Group type: EXPERIMENTAL
Intervention: Genetic correlation with body fat % and fat-free mass in anorexia nervosa, schizophrenia, and obsessive-compulsive disorder.
Number of subjects: 217568

Group type: EXPERIMENTAL
Intervention: Genetic correlation with body fat % and fat-free mass in ADHD, alcohol dependence, insomnia, and heavy smoking.
Number of subjects: 217568

Group type: EXPERIMENTAL
Intervention: Mendelian randomization for schizophrenia, anorexia nervosa, and higher education.
Number of subjects: 217568

Group type: EXPERIMENTAL
Intervention: Higher body fat % as a risk factor for ADHD and heavy smoking.
Number of subjects: 217568

Group type: EXPERIMENTAL
Intervention: Education years and ADHD genetic overlap with childhood obesity.
Number of subjects: 217568
Study: 28836546

Group type: EXPERIMENTAL
Intervention: Space Glucose Control (SGC) system
Number of subjects: 70

Group type: COMPARATOR
Intervention: Routine glucose management
Number of subjects: 70
Study: 25667240

Group type: EXPERIMENTAL
Intervention: Baseline PSQ score increase (1-SD)
Number of subjects: 185

Group type: EXPERIMENTAL
Intervention: Higher baseline PSQ scores (greater symptom burden)
Number of subjects: 185

Group type: COMPARATOR
Intervention: Polysomnographic data
Number of subjects: 185

Group type: COMPARATOR
Intervention: PSQ and polysomnographic data
Number of subjects: 185
Study: 25087079

Group type: EXPERIMENTAL
Intervention: Endurance-trained athletes (ETs)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Both groups (ETs and NAs)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Indexed left ventricular end-diastolic volume
Number of subjects: 60
Study: 21780182

Group type: EXPERIMENTAL
Intervention: B vitamins (0.8 mg folic acid, 0.5 mg vitamin B12, 20 mg vitamin B6)
Number of subjects: 266

Group type: EXPERIMENTAL
Intervention: B vitamins
Number of subjects: 266

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 266
Study: 19089502

Group type: EXPERIMENTAL
Intervention: Gabapentin
Number of subjects: 3

Group type: COMPARATOR
Intervention: Tricyclic antidepressants
Number of subjects: 3
Study: 17444926

Group type: EXPERIMENTAL
Intervention: Eating carrots and resisting cookies (high self-regulatory effort)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Eating cookies and resisting carrots (low self-regulatory effort)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Baseline HRV
Number of subjects: 0
Study: 15189364

Group type: EXPERIMENTAL
Intervention: Impaired fasting glucose (IFG)
Number of subjects: 2631

Group type: EXPERIMENTAL
Intervention: Impaired glucose tolerance (IGT)
Number of subjects: 2631

Group type: EXPERIMENTAL
Intervention: Type 2 diabetes incidence
Number of subjects: 2631
Study: 12358304

Group type: EXPERIMENTAL
Intervention: Topical instillation of non-selective beta-adrenoceptor antagonist (timolol)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Topical instillation of selective beta-adrenoceptor antagonist (betaxolol)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Short (10 s) and long (3 min) duration far (0D) and near (3D above tonic level) tasks
Number of subjects: 0
Study: 9103279

Group type: EXPERIMENTAL
Intervention: Acetylsalicylic acid
Number of subjects: 17

Group type: COMPARATOR
Intervention: Fruits and vegetables
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Urinary excretion of salicylates
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Diets with (acetyl)salicylic acid
Number of subjects: 17
Study: 10148570

Group type: EXPERIMENTAL
Intervention: Heparin-coated circuit
Number of subjects: 6

Group type: COMPARATOR
Intervention: Non heparin-coated circuit with systemic heparin
Number of subjects: 6
Study: 2423061

Group type: EXPERIMENTAL
Intervention: Argon laser photocoagulation
Number of subjects: 565

Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 565
Study: 31876749

Group type: EXPERIMENTAL
Intervention: Bronchoscopy alveolar lavage combined with thoracoscopy
Number of subjects: 174

Group type: COMPARATOR
Intervention: Thoracoscopy (Control Group A)
Number of subjects: 174
Study: 29124826

Group type: EXPERIMENTAL
Intervention: Nudge intervention
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: High-intensity hygiene education (HE) intervention
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Simultaneous delivery of HE intervention
Number of subjects: 20

Group type: COMPARATOR
Intervention: Sequential delivery of HE intervention
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Simultaneous nudge intervention delivery
Number of subjects: 20

Group type: COMPARATOR
Intervention: Sequential nudge intervention delivery
Number of subjects: 20
Study: 26863152

Group type: EXPERIMENTAL
Intervention: 14-week complex physical activity intervention
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Coaches' perceptions of intervention fidelity
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Total cost of developing the intervention and providing training
Number of subjects: 0
Study: 24440236

Group type: EXPERIMENTAL
Intervention: Suprapubic tube drainage with early urethral catheter removal (removed on postoperative day 1)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Urethral catheter drainage alone (catheter removed on postoperative day 7)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Suprapubic tube drainage with early urethral catheter removal
Number of subjects: 58

Group type: COMPARATOR
Intervention: Urethral catheter drainage alone
Number of subjects: 58
Study: 22505499

Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 200

Group type: COMPARATOR
Intervention: Glyburide
Number of subjects: 200
Study: 20456841

Group type: EXPERIMENTAL
Intervention: Integrative respiratory rehabilitation training (Group D)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Modern rehabilitation training (Group C)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Traditional qigong training (Group B)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Drug therapy (Group A)
Number of subjects: 80
Study: 18588557

Group type: EXPERIMENTAL
Intervention: Introduction schedules for common allergenic foods
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Positive challenges (37)
Number of subjects: 63
Study: 16100296

Group type: EXPERIMENTAL
Intervention: Crushed tablets mixed in 240 mL nutritional supplement drink followed by 120 mL water
Number of subjects: 32

Group type: COMPARATOR
Intervention: Whole tablets swallowed with 240 mL water
Number of subjects: 32
Study: 12413755

Group type: EXPERIMENTAL
Intervention: Laryngeal tube
Number of subjects: 28

Group type: COMPARATOR
Intervention: Laryngeal mask
Number of subjects: 28
Study: 10609978

Group type: EXPERIMENTAL
Intervention: Chewing gum (participants were asked to chew at least one piece of gum and had free access to chewing gum throughout the experimental session)
Number of subjects: 20

Group type: COMPARATOR
Intervention: No-gum control (participants did not chew gum)
Number of subjects: 20
Study: 8935118

Group type: EXPERIMENTAL
Intervention: Fuji II LC
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Photac‐Fil
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Vitremer
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: All materials
Number of subjects: 13
Study: 1648432

Group type: EXPERIMENTAL
Intervention: RTOG Staging System
Number of subjects: 850

Group type: EXPERIMENTAL
Intervention: RTOG Stage III (462 patients)
Number of subjects: 850

Group type: EXPERIMENTAL
Intervention: AJCC Stage IIIA (348 patients)
Number of subjects: 850
Study: 6360038

Group type: EXPERIMENTAL
Intervention: Ceftazidime
Number of subjects: 77

Group type: COMPARATOR
Intervention: Clindamycin-tobramycin
Number of subjects: 77
Study: 31711528

Group type: COMPARATOR
Intervention: Standard doses (20 μg IM at months 0, 1, and 6); n=44
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Four doses (20 μg IM at months 0, 1, 2, 6); n=44
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Four double doses (40 μg IM at months 0, 1, 2, and 6); n=44
Number of subjects: 132
Study: 29446267

Group type: EXPERIMENTAL
Intervention: Facial mask with silicone chin cup
Number of subjects: 200

Group type: COMPARATOR
Intervention: Facial mask without silicone chin cup
Number of subjects: 200
Study: 26811090

Group type: EXPERIMENTAL
Intervention: Saffron (300 mg/day for 10 days)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study: 24535415

Group type: EXPERIMENTAL
Intervention: Guanidinoacetic acid (GAA) at dosages of 1.2, 2.4, and 4.8 g/day for 6 weeks
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Guanidinoacetic acid (GAA) at high dosage (4.8 g/day)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Guanidinoacetic acid (GAA)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study: 22277680

Group type: EXPERIMENTAL
Intervention: Thalidomide plus arsenic trioxide (ATO)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Supportive care
Number of subjects: 22
Study: 20394254

Group type: EXPERIMENTAL
Intervention: Dextromethorphan 45 mg
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Dextromethorphan 90 mg
Number of subjects: 72

Group type: COMPARATOR
Intervention: Placebo (Control)
Number of subjects: 72
Study: 17110451

Group type: EXPERIMENTAL
Intervention: Vitamin K supplementation (150 mug daily for 6 months)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study: 16354361

Group type: EXPERIMENTAL
Intervention: Thyroidectomy
Number of subjects: 41
Study: 12468788

Group type: EXPERIMENTAL
Intervention: Gait trainer therapy (2 weeks)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Treadmill therapy (2 weeks)
Number of subjects: 30
Study: 9672577

Group type: EXPERIMENTAL
Intervention: Mandatory training program for managers
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Voluntary training program for managers
Number of subjects: 94

Group type: COMPARATOR
Intervention: Control group (no training)
Number of subjects: 94
Study: 8605522

Group type: EXPERIMENTAL
Intervention: Oral cholera vaccine (rBS/WC)
Number of subjects: 1165

Group type: COMPARATOR
Intervention: Placebo (killed Escherichia coli K12)
Number of subjects: 1165
Study: 2686256

Group type: EXPERIMENTAL
Intervention: Aspirin (500 mg/day) added to nitrates, beta-blockers, and calcium entry blockers
Number of subjects: 27

Group type: COMPARATOR
Intervention: Nitrates, beta-blockers, and calcium entry blockers (without aspirin)
Number of subjects: 27
Study: 4610853

Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygen treatment within the first 24 hours of thermal injuries
Number of subjects: 191

Group type: EXPERIMENTAL
Intervention: Percentage of burn
Number of subjects: 191
Study: 31521046

Group type: EXPERIMENTAL
Intervention: Seven-day shared decision making (SDM) program
Number of subjects: 88

Group type: COMPARATOR
Intervention: Usual care (Control)
Number of subjects: 88
Study: 28382877

Group type: EXPERIMENTAL
Intervention: Minor alleles of CYP2R1 rs10500804, GC rs4588 and rs7041
Number of subjects: 642

Group type: EXPERIMENTAL
Intervention: Minor alleles homozygosity of rs10741657 and rs1562902 in CYP2R1
Number of subjects: 642

Group type: EXPERIMENTAL
Intervention: GC rs7041
Number of subjects: 642
Study: 25773378

Group type: EXPERIMENTAL
Intervention: Alirocumab (150 mg)
Number of subjects: 2341

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2341

Group type: EXPERIMENTAL
Intervention: Alirocumab
Number of subjects: 2341
Study: 22090268

Group type: EXPERIMENTAL
Intervention: Pump delivery of PTH 1-34
Number of subjects: 8
Study: 20370312

Group type: EXPERIMENTAL
Intervention: BIT (Behavioral Internet Treatment)
Number of subjects: 442

Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 442
Study: 18358369

Group type: EXPERIMENTAL
Intervention: Highly cross-linked polyethylene (HXLPE)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Standard ultra-high-molecular-weight polyethylene (UHMWPE)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Both polyethylene types
Number of subjects: 54
Study: 15999906

Group type: EXPERIMENTAL
Intervention: Psychotropic drugs (sedative and non-sedative neuroleptics, antidepressants, tranquilizers, hypnotics, psychostimulants, cognition-enhancing drugs)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: COMPARATOR
Intervention: Normal controls
Number of subjects: 0
Study: 12113585

Group type: EXPERIMENTAL
Intervention: PSA velocity (PSAV) in non-cancer subjects
Number of subjects: 1666

Group type: EXPERIMENTAL
Intervention: PSA velocity (PSAV) in cancer patients
Number of subjects: 1666

Group type: COMPARATOR
Intervention: PSAV cutoff of 0.75 ng/mL/year
Number of subjects: 1666

Group type: COMPARATOR
Intervention: PSAV cutoff of 0.10 ng/mL/year
Number of subjects: 1666
Study: 10529071

Group type: EXPERIMENTAL
Intervention: Lithium
Number of subjects: 57

Group type: COMPARATOR
Intervention: Carbamazepine
Number of subjects: 57
Study: 7747716

Group type: EXPERIMENTAL
Intervention: Orchidectomy and mitomycin C
Number of subjects: 178

Group type: COMPARATOR
Intervention: Orchidectomy alone
Number of subjects: 178
Study: 2188479

Group type: EXPERIMENTAL
Intervention: mianserin (up to 90 mg per day)
Number of subjects: 48

Group type: COMPARATOR
Intervention: maprotiline (up to 150 mg per day)
Number of subjects: 48
Study: 6117728

Group type: EXPERIMENTAL
Intervention: Bone‐marrow transplant from a matched allogeneic sibling
Number of subjects: 2

Group type: COMPARATOR
Intervention: Drugs to induce initial remission
Number of subjects: 2
Study: 31900198

Group type: EXPERIMENTAL
Intervention: Escitalopram or Nortriptyline
Number of subjects: 380
Study: 30456970

Group type: EXPERIMENTAL
Intervention: Parents who took their children for eye tests
Number of subjects: 173

Group type: EXPERIMENTAL
Intervention: Parents' acceptance of children wearing spectacles
Number of subjects: 173

Group type: EXPERIMENTAL
Intervention: Parents' knowledge about child eye conditions
Number of subjects: 173

Group type: EXPERIMENTAL
Intervention: Association between family member wearing spectacles and child eye testing
Number of subjects: 173

Group type: EXPERIMENTAL
Intervention: Association between education level and knowledge of eye conditions
Number of subjects: 173

Group type: EXPERIMENTAL
Intervention: Knowledge about eye health with family member wearing spectacles
Number of subjects: 173
Study: 27502805

Group type: EXPERIMENTAL
Intervention: Foot reflexology treatment
Number of subjects: 120

Group type: COMPARATOR
Intervention: Nonspecific foot massage
Number of subjects: 120
Study: 24817242

Group type: EXPERIMENTAL
Intervention: Rhinotopic protocol consisting of twice-daily saline rinses, nebulized corticosteroid, and nebulized antibiotic for 6 weeks, followed by once-weekly endoscopic sinus debridement and topical intrasinus installation of corticosteroid and antibiotic.
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Rhinotopic protocol
Number of subjects: 20